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HTLV-1 propagates in the host by two parallel mechan-
isms: infectious spread, i.e. direct transfer of virions
from cell to cell via the virological synapse; and mitotic
spread, i.e. proliferation of HTLV-1-infected T cell
clones. During chronic infection, mitotic spread predo-
minates, generating very large clones in some indivi-
duals. Yet the reasons for the remarkable variation
within and between hosts in the abundance of HTLV-1-
infected clones remain unknown.
We aim to identify and quantify the selection forces
that determine the size of HTLV-1-infected T cell
clones in vivo and hence the risk of the associated
inflammatory and malignant diseases. We shall summar-
ize evidence from host and viral genetics, cellular immu-
nology and high-throughput proviral integration site
analysis that:
1. The ‘quality’ or efficiency of a person’s genetically-
determined cytotoxic T lymphocyte (CTL) response to
the HBZ protein is a major determinant of that person’s
proviral load and the risk of inflammatory diseases.
2. The chief determinant of CTL quality is the host
genotype in HLA Class 1 and Killer cell Immunoglobu-
lin-like Receptor (KIR) loci.
3. The CTL response to the Tax protein is immuno-
dominant but does not protect against HAM/TSP.
4. The site and orientation of the HTLV-1 provirus
integrated in the T cell genome determine the size of
each T cell clone in the host.
5. Negative selection on the virus dominates during
chronic infection: we postulate that this selection is
exerted by CTLs.
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